Abbott Laboratories Total Assets 2006-2019 | ABT

Abbott Laboratories total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Abbott Laboratories total assets for the quarter ending December 31, 2019 were $67.887B, a 1.06% increase year-over-year.
  • Abbott Laboratories total assets for 2019 were $67.887B, a 1.06% increase from 2018.
  • Abbott Laboratories total assets for 2018 were $67.173B, a 11.9% decline from 2017.
  • Abbott Laboratories total assets for 2017 were $76.25B, a 44.78% increase from 2016.
Abbott Laboratories Annual Total Assets
(Millions of US $)
2019 $67,887
2018 $67,173
2017 $76,250
2016 $52,666
2015 $41,247
2014 $41,207
2013 $42,953
2012 $67,235
2011 $60,277
2010 $60,574
2009 $52,582
2008 $42,419
2007 $39,714
2006 $36,178
2005 $29,141
Abbott Laboratories Quarterly Total Assets
(Millions of US $)
Q4 2019 $67,887
Q3 2019 $68,539
Q2 2019 $68,427
Q1 2019 $67,610
Q4 2018 $67,173
Q3 2018 $71,637
Q2 2018 $68,415
Q1 2018 $70,908
Q4 2017 $76,250
Q3 2017 $72,248
Q2 2017 $71,151
Q1 2017 $70,887
Q4 2016 $52,666
Q3 2016 $39,497
Q2 2016 $39,831
Q1 2016 $39,637
Q4 2015 $41,247
Q3 2015 $41,725
Q2 2015 $44,125
Q1 2015 $43,095
Q4 2014 $41,207
Q3 2014 $42,514
Q2 2014 $41,475
Q1 2014 $41,662
Q4 2013 $42,953
Q3 2013 $44,132
Q2 2013 $42,903
Q1 2013 $42,687
Q4 2012 $67,235
Q3 2012 $63,258
Q2 2012 $61,860
Q1 2012 $62,416
Q4 2011 $60,277
Q3 2011 $59,628
Q2 2011 $62,004
Q1 2011 $61,651
Q4 2010 $60,574
Q3 2010 $57,374
Q2 2010 $53,381
Q1 2010 $53,359
Q4 2009 $52,582
Q3 2009 $49,847
Q2 2009 $47,630
Q1 2009 $45,438
Q4 2008 $42,419
Q3 2008 $41,753
Q2 2008 $44,074
Q1 2008 $41,178
Q4 2007 $39,714
Q3 2007 $37,622
Q2 2007 $37,153
Q1 2007 $36,286
Q4 2006 $36,178
Q3 2006 $33,300
Q2 2006 $34,061
Q1 2006 $28,532
Q4 2005 $29,141
Q3 2005 $28,831
Q2 2005 $27,817
Q1 2005 $28,857
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $143.473B $31.904B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $142.281B 19.13
Stryker (SYK) United States $75.537B 24.41
Boston Scientific (BSX) United States $54.996B 24.77
Baxter (BAX) United States $44.434B 26.94
Lonza Group Ag (LZAGY) Switzerland $30.852B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $30.514B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.251B 18.62
Coloplast (CLPBY) Denmark $29.138B 44.97
Terumo (TRUMY) Japan $24.711B 30.84
ResMed (RMD) United States $23.995B 41.69
Smith & Nephew SNATS (SNN) United Kingdom $20.792B 0.00
Sunny Optical Technology (SNPTF) China $18.060B 0.00
Insulet (PODD) United States $11.129B 692.35
Bio-Rad Laboratories (BIO) United States $11.046B 51.61
Perrigo (PRGO) Ireland $8.258B 15.40
William Demant Holdings (WILYY) Denmark $7.896B 0.00
GN STORE NORD (GNNDY) Denmark $7.537B 38.94
Canopy Growth (CGC) Canada $6.924B 0.00
Hill-Rom Holdings (HRC) United States $6.809B 19.58
DiaSorin S.p.A (DSRLF) Italy $6.446B 0.00
Haemonetics (HAE) United States $5.461B 33.61
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
ICU Medical (ICUI) United States $4.224B 27.54
Envista Holdings (NVST) United States $4.210B 0.00
NuVasive (NUVA) United States $3.603B 27.86
Neogen (NEOG) United States $3.585B 59.66
Quidel (QDEL) United States $3.390B 29.76
Agios Pharmaceuticals (AGIO) United States $3.314B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.305B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.193B 0.00
National Vision Holdings (EYE) United States $3.054B 52.16
Aurora Cannabis (ACB) Canada $1.765B 0.00
AtriCure (ATRC) United States $1.600B 0.00
TG Therapeutics (TGTX) United States $1.381B 0.00
Cardiovascular Systems (CSII) United States $1.343B 0.00
NanoString Technologies (NSTG) United States $1.171B 0.00
InMode (INMD) Israel $1.096B 0.00
Phibro Animal Health (PAHC) United States $1.049B 20.74
Aphria (APHA) $1.020B 0.00
PetIQ (PETQ) United States $0.926B 22.58
VAREX IMAGING (VREX) United States $0.917B 19.06
Cerus (CERS) United States $0.851B 0.00
Quanterix (QTRX) United States $0.695B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.666B 25.49
DFB Healthcare Acquisitions (AHCO) United States $0.653B 124.62
Lantheus Holdings (LNTH) United States $0.640B 14.55
Omeros (OMER) United States $0.633B 0.00
LeMaitre Vascular (LMAT) United States $0.590B 33.51
MacroGenics (MGNX) United States $0.588B 0.00
Surmodics (SRDX) United States $0.494B 56.80
Zynex (ZYXI) United States $0.414B 46.78
Owens & Minor (OMI) United States $0.412B 15.23
Organigram Holdings (OGI) Canada $0.384B 0.00
OraSure Technologies (OSUR) United States $0.374B 46.62
HEXO (HEXO) $0.352B 0.00
Utah Medical Products (UTMD) United States $0.349B 24.84
Meridian Bioscience (VIVO) United States $0.320B 12.88
Evolus (EOLS) United States $0.305B 0.00
BioLife Solutions (BLFS) United States $0.303B 123.42
Repro-Med Systems (KRMD) United States $0.278B 176.00
Female Health (VERU) United States $0.277B 0.00
Bovie Medical (APYX) United States $0.238B 0.00
InfuSystems Holdings (INFU) United States $0.206B 1039.00
Rockwell Medical (RMTI) United States $0.203B 0.00
Vapotherm (VAPO) United States $0.203B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.201B 0.00
Cytosorbents (CTSO) United States $0.183B 0.00
Viemed Healthcare (VMD) United States $0.183B 19.24
United Health Products (UEEC) United States $0.180B 0.00
Liberty Health Sciences (LHSIF) Canada $0.137B 0.00
Fonar (FONR) United States $0.129B 9.39
Green Organic Dutchman Holdings (TGODF) Canada $0.128B 0.00
Chimerix (CMRX) United States $0.115B 0.00
MTech Acquisition (KERN) United States $0.102B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.084B 0.00
Surface Oncology (SURF) United States $0.078B 0.00
United-Guardian (UG) United States $0.077B 19.36
Chembio Diagnostics (CEMI) United States $0.067B 0.00
Nephros (NEPH) United States $0.067B 0.00
FSD PHARMA INC (HUGE) Canada $0.042B 0.00
NF Energy Saving (BIMI) China $0.037B 0.00
ImmuCell (ICCC) United States $0.035B 0.00
GUARDION HEALTH (GHSI) United States $0.023B 0.00
Trinity Biotech (TRIB) Ireland $0.023B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.014B 0.00
Senestech (SNES) United States $0.006B 0.00
Capricor Therapeutics (CAPR) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Myomo (MYO) United States $0.003B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00